Media Inquiries: For all MAVA media inquiries, please contact us at 703-506-9300 or email email@example.com.
Check back regularly for news, coverage, and announcements about MAVA.
Baltimore biopharmaceutical firm Cerecor Inc. has raised $32 million in a Series B fundraising round led by New Enterprise Associates, Apple Tree Partners and MPM Capital.
Multiplier Capital, a venture debt fund with established excellence in growth capital lending, today announced the final closing of its first fund, Multiplier Capital, LP, with investable capital of approximately $227 million.
Promising news for any unlucky american in immediate need of a doctor: BetterDoctor, the San Francisco based healthcare tool and online doctor search service, has closed a $10 million Series A funding round led by New Enterprise Associates and participated by existing investors including SoftTechVC and Finnish venture capital firm Lifeline Ventures.
Baltimore-area companies took home 12 percent of the money venture firms invested in the Baltimore-Washington, D.C., region in the second quarter.
Company Achieves First Ever Placement, Based on Completeness of Vision and Ability to Execute
Motionsoft, which sells check-in, billing and other management software to fitness clubs, on Tuesday announced a $10 million Series B funding led by Alexandria-based Route 66 Ventures.
Edison Ventures, the New Jersey-based venture capital firm with offices in McLean, said on Monday it has changed its name to Edison Partners.
egent Education, the leading provider of financial aid management and enrollment optimization software solutions for higher education institutions, today announced a $9 million round of funding to support and accelerate the company's growth.
Paladin Capital Group is pleased to announce that the former Deputy Director of the NSA Chris Inglis has joined Paladin as a Venture Partner.
An Acentia subsidiary has won a five-year, $68 million contract to provide information technology services to the Internal Revenue Service‘s data delivery organization.